| Literature DB >> 25859876 |
Luiz Fernando Kubrusly1, Marina Simões Formighieri2, José Vitor Martins Lago2, Yorgos Luiz Santos de Salles Graça2, Ana Cristina Lira Sobral2, Marianna Martins Lago3.
Abstract
OBJECTIVE: To evaluate the behavior of castor oil-derived polyurethane as a hemostatic agent and tissue response after abdominal aortic injury and to compare it with 2-octyl-cyanoacrylate.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25859876 PMCID: PMC4389526 DOI: 10.5935/1678-9741.20140125
Source DB: PubMed Journal: Rev Bras Cir Cardiovasc
Fig. 1Proximal and distal clamping of the aorta with Bulldog De Bakey and hemostasis with polyurethane
Comparison of groups IIA (polyurethane A), IIB (polyurethane B), and III (cyanoacrylate) regarding the intraoperative variables
| Variable | Group | N | Mean | Minimum | Maximum | SD | |
|---|---|---|---|---|---|---|---|
| Application Time (seconds) | Cyanoacrylate | 8 | 53.7 | 25.7 | 89.0 | 24.4 | |
| Polyurethane A | 4 | 55.2 | 34.4 | 63.9 | 13.9 | ||
| Polyurethane B | 4 | 45.0 | 26.6 | 69.9 | 20.7 | 0.810 | |
| Drying Time (seconds) | Cyanoacrylate | 8 | 81.5 | 33.50 | 192.8 | 51.5 | |
| Polyurethane A | 4 | 40.5 | 28.2 | 48.4 | 8.6 | ||
| Polyurethane B | 4 | 126.1 | 102.8 | 156.6 | 23.0 | 0.023 | |
| Blood Loss (grams) | Cyanoacrylate | 8 | 0.170 | 0.0000 | 1.220 | 0.424 | |
| Polyurethane A | 4 | 0.002 | 0.000 | 0.010 | 0.005 | ||
| Polyurethane B | 4 | 0.008 | 0.000 | 0.010 | 0.005 | 0.069 |
Nonparametric Kruskal-Wallis test, P<0.05
Percentage of fibrosis in groups I, II, and III
| Group | |||
|---|---|---|---|
| Fibrosis | Control | Polyurethane | Cyanoacrylate |
| Absent/Mild | 4 | 7 | 0 |
| 57.14% | 87.50% | 0.00% | |
| Moderate/Severe | 3 | 1 | 7 |
| 42.86% | 12.50% | 100.00% | |
| Total | 7 | 8 | 7 |
Fig. 2Fibrosis absent/mild in polyurethane group (left) and moderate/severe in the cyanoacrylate group (right) stained with Masson’s trichrome
Comparison of groups I, II, and III in relation to the histological quantitative variables
| Anatomo-pathological
Variables | Group | N | Mean | Median | Minimum | Maximum | SD | |
|---|---|---|---|---|---|---|---|---|
| Histiocytes | Cyanoacrylate | 7 | 47.0 | 25 | 18 | 112 | 40.6 | 0.094 |
| Polyurethane | 8 | 26.1 | 12 | 0 | 135 | 44.4 | ||
| Control | 7 | 28.4 | 12 | 0 | 120 | 42.6 | ||
| Neutrophils | Cyanoacrylate | 7 | 17.1 | 8 | 4 | 54 | 18.1 | 0.254 |
| Polyurethane | 8 | 15.1 | 4.5 | 0 | 54 | 21.4 | ||
| Control | 7 | 4.3 | 5 | 0 | 8 | 3.4 | ||
| Lymphocytes | Cyanoacrylate | 7 | 58.3 | 22 | 12 | 220 | 74.9 | 0.267 |
| Polyurethane | 8 | 32.3 | 10.5 | 7 | 120 | 42.4 | ||
| Control | 7 | 26.0 | 10 | 5 | 82 | 28.8 | ||
| Giant cells | Cyanoacrylate | 7 | 2.7 | 3 | 0 | 6 | 2.3 | 0.578 |
| Polyurethane | 8 | 1.5 | 0 | 0 | 4 | 2.1 | ||
| Control | 7 | 2.9 | 0 | 0 | 12 | 5.0 |
Counting the number of respective cells in five microscopic fields at 400x
Nonparametric Kruskal-Wallis test, P<0.05
| Authors’ roles & responsibilities | |
|---|---|
| LFK | Analysis and/or interpretation of data, final approval of the manuscript, conception and design of the study, implementation of operations and/or experiments, manuscript writing or critical review of its content |
| MSF | Analysis and/or interpretation of data, final approval of the manuscript, conception and design of the study, implementation of operations and/or experiments, manuscript writing or critical review of its content |
| JVML | Analysis and/or interpretation of data, final approval of the manuscript, conception and design of the study, implementation of operations and/or experiments, manuscript writing or critical review of its content |
| YLSSG | Conception and design of the study, implementation of operations and/or experiments, manuscript writing or critical review of its content |
| ACLS | Analysis and/or interpretation of data |
| MML | Manuscript writing or critical review of its content |